281
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Condition(s): Diabetes Mellitus, Type 2 Last Updated: April 12, 2013Completed
2137 Clinical Trials for: Subcutaneous Injection, Page 15 of 107
Hide Studies Not Seeking New Volunteers
282
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
Condition(s): Prostate Cancer Last Updated: March 31, 2013Recruiting
283
A Study to Evaluate 3 Different Dosing Regimens of Mipomersen Administered Via Subcutaneous Injections to Healthy Volunteers
Condition(s): Healthy Volunteer Last Updated: July 16, 2010Completed
284
A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
Condition(s): Psoriasis Last Updated: January 14, 2013Completed
285
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use
Condition(s): Psoriasis Last Updated: May 27, 2010Recruiting
286
Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler
Condition(s): Healthy Last Updated: September 5, 2012Completed
287
Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers
Condition(s): Healthy Last Updated: January 14, 2013Not yet recruiting
288
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis
Condition(s): Rheumatoid Arthritis Last Updated: May 10, 2013Recruiting
289
A Multicentre Phase III Study of Interferon-Beta-1a for the Treatment of Chronic Hepatitis C in Asian Patients
Condition(s): Hepatitis C Last Updated: March 21, 2009Completed
290
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Condition(s): Chronic Fatigue Syndrome; Myalgic Encephalomyelitis Last Updated: November 15, 2012Recruiting
291
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee.
Condition(s): Osteoarthritis Last Updated: March 15, 2013Recruiting
292
Optimizing Insulin Absorption and Insulin Injection Technique in Older Adults
Condition(s): Diabetes Last Updated: November 21, 2011Recruiting
293
To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
Condition(s): Hidradenitis Suppurativa Last Updated: January 22, 2009Completed
294
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
Condition(s): Relapsing-Remitting Multiple Sclerosis Last Updated: June 27, 2011Completed
295
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
Condition(s): HIV Infections Last Updated: June 23, 2005Completed
296
Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C
Condition(s): Hepatitis C Last Updated: February 1, 2012Completed
297
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
Condition(s): Type 1 Diabetes; Preservation of Insulin Secretion; Newly Diagnosed Type 1 Diabetes; Canakinumab in Type 1 Diabetes Last Updated: March 5, 2012Active, not recruiting
298
Michelangelo - Oasis 5
Condition(s): Myocardial Infarction Last Updated: October 13, 2011Completed
299
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
Condition(s): Neoplasms; Deep Vein Thrombosis Last Updated: July 27, 2012Terminated
300
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Condition(s): Diabetes Mellitus, Type 2 Last Updated: March 8, 2013Recruiting
